Clinical Trials · NCT03878706
The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination
- Phase
- N/A
- Recruitment status
- Recruiting
- Sponsor
- University of Athens
- Enrollment
- 240
- Start date
- Nov 2017
- Locations
- 1 site, Greece
- Primary endpoint
- Comparison of Global Longitudinal Strain (GLS) difference among treatment groups.